Cairo – Mubasher: The Egyptian International Pharmaceutical Industries (EIPICO) announced that its EIPICO 2 and EIPICO 3 factories have reopened and resumed production after carrying out sanitisation and disinfection procedures and regular maintenance.
Factories resumed production as of Saturday, 30 May, according to a statement to the Egyptian Exchange (EGX) on Sunday.
It is noteworthy to mention that during the first quarter of 2020, EIPICO logged EGP 189.1 million in net profits, down from EGP 218.31 million in the year-ago period.
